theHarshFolio (@theharshfolio) 's Twitter Profile
theHarshFolio

@theharshfolio

Indian folio: forum.valuepickr.com/t/the-harsh-po…
Global folio: forum.valuepickr.com/t/the-harsh-gl…
@harshberia93

ID: 3279043753

calendar_today14-07-2015 00:12:37

2,2K Tweet

12,12K Takipçi

221 Takip Edilen

theHarshFolio (@theharshfolio) 's Twitter Profile Photo

Modison is confident to reach 1000 cr. sales by FY30. They are looking at product diversification as a growth strategy, current expansion will cater to growth in next few years. Detailed AGM notes at link below. forum.valuepickr.com/t/modison-meta…

Modison is confident to reach 1000 cr. sales by FY30. They are looking at product diversification as a growth strategy, current expansion will cater to growth in next few years. Detailed AGM notes at link below. 
forum.valuepickr.com/t/modison-meta…
theHarshFolio (@theharshfolio) 's Twitter Profile Photo

Wrote a detailed note on Eureka Forbes to consolidate my understanding of the company. Growth momentum continues in Q4 with margin expansion driven by operating leverage forum.valuepickr.com/t/eureka-forbe…

Wrote a detailed note on Eureka Forbes to consolidate my understanding of the company. Growth momentum continues in Q4 with margin expansion driven by operating leverage

forum.valuepickr.com/t/eureka-forbe…
Ajanta Pharma (@ajantapharmaltd) 's Twitter Profile Photo

𝐀𝐣𝐚𝐧𝐭𝐚 𝐝𝐨𝐞𝐬 𝐢𝐭 𝐚𝐠𝐚𝐢𝐧! We’re thrilled to share that Ajanta Pharma USA has won two prestigious DIANA Awards from the Healthcare Distribution Alliance (HDA) in the United States! 1. 𝐁𝐞𝐬𝐭 𝐎𝐯𝐞𝐫𝐚𝐥𝐥 𝐆𝐞𝐧𝐞𝐫𝐢𝐜 𝐌𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐞𝐫 We’ve made

𝐀𝐣𝐚𝐧𝐭𝐚 𝐝𝐨𝐞𝐬 𝐢𝐭 𝐚𝐠𝐚𝐢𝐧!

We’re thrilled to share that Ajanta Pharma USA has won two prestigious DIANA Awards from the Healthcare Distribution Alliance (HDA) in the United States!

1. 𝐁𝐞𝐬𝐭 𝐎𝐯𝐞𝐫𝐚𝐥𝐥 𝐆𝐞𝐧𝐞𝐫𝐢𝐜 𝐌𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐞𝐫

We’ve made
theHarshFolio (@theharshfolio) 's Twitter Profile Photo

3 years after the peak narrative of China+1 in pharma APIs, China reached its peak import market share. Over the long term, economics rules over narratives ! Source: CareEdge

3 years after the peak narrative of China+1 in pharma APIs, China reached its peak import market share. Over the long term, economics rules over narratives !
Source: CareEdge
Devesh Kayal (@_devesh_) 's Twitter Profile Photo

Ultramarine has done a good job in containing Power & Fuel costs over past 2 yrs from 7.4% of manufactured goods revenue to 6% now.

Ultramarine has done a good job in containing Power & Fuel costs over past 2 yrs from 7.4% of manufactured goods revenue to 6% now.
theHarshFolio (@theharshfolio) 's Twitter Profile Photo

Ultramarine continues their capex plans, they have now acquired a 33 acre land parcel (probably for another greenfield) in FY25. Most expansion funded via internal accruals

Ultramarine continues their capex plans, they have now acquired a 33 acre land parcel (probably for another greenfield) in FY25. Most expansion funded via internal accruals
theHarshFolio (@theharshfolio) 's Twitter Profile Photo

Was surprised why Accent's MCC realizations looked very high (300/kg) vs Sigachi's (215/kg). Screener.in AI resolved this in 5 mins: there was an additional 3k MT of semi-processed MCC above 9k MT manufactured. Realization corrected to ~220/kg. Explosion in productivity !

Was surprised why Accent's MCC realizations looked very high (300/kg) vs Sigachi's (215/kg). 

<a href="/screener_in/">Screener.in</a> AI resolved this in 5 mins: there was an additional 3k MT of semi-processed MCC above 9k MT manufactured. Realization corrected to ~220/kg. 

Explosion in productivity !
Yogansh Jeswani, CFA (@yoganshjeswani) 's Twitter Profile Photo

A big day for Screener.in — our new AI tool is live! Experience it yourself and see what it can do. This is a big leap & I’m super excited! 😊 More power to you Bhaiya Pratyush Mittal Ayush Mittal #screener #AI

A big day for Screener.in — our new AI tool is live!

Experience it yourself and see what it can do. This is a big leap &amp; I’m super excited! 😊

More power to you Bhaiya <a href="/faltoo/">Pratyush Mittal</a> <a href="/ayushmitt/">Ayush Mittal</a> 

#screener 
#AI
Ayush Mittal (@ayushmitt) 's Twitter Profile Photo

I'm very happy and excited with the launch of Screener AI. This is probably one of the most useful tool we have been able to bring to our users. I have been trying Screener AI for last 3 months. Initially, I had a bit of disbelief; however, with more usage, I realized the power

Pratyush Mittal (@faltoo) 's Twitter Profile Photo

Vishnu Prasad V P mukesh sahni 🌱We have made major improvements in the web-search in Screener AI. Screener AI reads official company documents for providing answers. It does a web-search when the documents don't provide enough info. This has improved a lot. Thanks to Rahil Dasani.

<a href="/vlockn/">Vishnu Prasad V P</a> <a href="/mukeshsahnis/">mukesh sahni</a> 🌱We have made major improvements in the web-search in Screener AI.

Screener AI reads official company documents for providing answers. It does a web-search when the documents don't provide enough info. This has improved a lot.

Thanks to <a href="/rahildasani13/">Rahil Dasani</a>.
theHarshFolio (@theharshfolio) 's Twitter Profile Photo

After a bumper FY25, net MF flows have turned negative in the last few months. Anytime market comes out a downturn, the net flows happen at a lag

After a bumper FY25, net MF flows have turned negative in the last few months. Anytime market comes out a downturn, the net flows happen at a lag
theHarshFolio (@theharshfolio) 's Twitter Profile Photo

The NCR real estate prices have seen a crazy upswing moving past MMR post Covid. Who saw this coming? Source: Nuvama/Propquity

The NCR real estate prices have seen a crazy upswing moving past MMR post Covid. Who saw this coming? 

Source: Nuvama/Propquity
Pratyush Mittal (@faltoo) 's Twitter Profile Photo

Vishnu Prasad V P mukesh sahni Rahil Dasani 🪄 Made many improvements in Screener AI over last few days: - Lots of cost optimizations in edge cases. Sometimes same document was read multiple times. Fixed it. - Reduced "no response" cases from 2.5% to 0.1%. Major price optimizations (and quality improvements) coming up.

Ankit (@stocksandstoics) 's Twitter Profile Photo

India Pesticides management guided for 1,000 cr. (20% growth) of revenue for FY26 and further 15-20% revenue growth in FY27 with EBITDA margins of 18-20%, during its Q1FY26 concall today. The company is incurring a capex of ~116 cr. in FY26 primarily from internal accrual